Nisa Investment Advisors, LLC Agenus Inc Transaction History

Nisa Investment Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$0.63 - $1.14 $11,770 - $21,299	-18,684 Reduced 98.6%	266 $0
Q3 2023 Nov 02, 2023	SELL	$1.12 - $1.88 $12,997 - $21,817	-11,605 Reduced 37.98%	18,950 $21,000
Q2 2023 Aug 11, 2023	BUY	$1.31 - $2.04 $21,755 - $33,878	16,607 Added 119.06%	30,555 $48,000
Q1 2023 May 02, 2023	BUY	$1.45 - $2.95 $127 - $259	88 Added 0.63%	13,948 $21,000
Q4 2022 Feb 02, 2023	SELL	$2.02 - $3.25 $533 - $858	-264 Reduced 1.87%	13,860 $33,000
Q3 2022 Nov 07, 2022	BUY	$1.96 - $3.14 $517 - $828	264 Added 1.9%	14,124 $36,000
Q2 2022 Aug 03, 2022	BUY	$1.3 - $2.64 $14,690 - $29,832	11,300 Added 441.41%	13,860 $27,000
Q4 2020 Jan 25, 2021	BUY	$3.17 - $4.49 $2,536 - $3,592	800 Added 45.45%	2,560 $8,000
Q1 2020 Apr 17, 2020	SELL	$1.92 - $4.39 $1,574 - $3,599	-820 Reduced 31.78%	1,760 $4,000
Q3 2019 Oct 17, 2019	BUY	$2.17 - $3.14 $3,710 - $5,369	1,710 Added 196.55%	2,580 $7,000
Q3 2018 Oct 16, 2018	BUY	$1.59 - $2.42 $1,383 - $2,105	870 New	870 $2,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.